BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 12161538)

  • 1. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
    Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
    Cheung L; Messina M; Gill A; Clarkson A; Learoyd D; Delbridge L; Wentworth J; Philips J; Clifton-Bligh R; Robinson BG
    J Clin Endocrinol Metab; 2003 Jan; 88(1):354-7. PubMed ID: 12519876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
    Nikiforova MN; Lynch RA; Biddinger PW; Alexander EK; Dorn GW; Tallini G; Kroll TG; Nikiforov YE
    J Clin Endocrinol Metab; 2003 May; 88(5):2318-26. PubMed ID: 12727991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.
    Lacroix L; Mian C; Barrier T; Talbot M; Caillou B; Schlumberger M; Bidart JM
    Eur J Endocrinol; 2004 Sep; 151(3):367-74. PubMed ID: 15362967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is thyroid follicular cancer in Japanese caused by a specific t(2; 3)(q13; p25) translocation generating Pax8-PPAR gamma fusion mRNA?
    Hibi Y; Nagaya T; Kambe F; Imai T; Funahashi H; Nakao A; Seo H
    Endocr J; 2004 Jun; 51(3):361-6. PubMed ID: 15256783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.
    Nikiforova MN; Biddinger PW; Caudill CM; Kroll TG; Nikiforov YE
    Am J Surg Pathol; 2002 Aug; 26(8):1016-23. PubMed ID: 12170088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation.
    Castro P; Roque L; Magalhães J; Sobrinho-Simões M
    Int J Surg Pathol; 2005 Jul; 13(3):235-8. PubMed ID: 16086077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors.
    Dwight T; Thoppe SR; Foukakis T; Lui WO; Wallin G; Höög A; Frisk T; Larsson C; Zedenius J
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4440-5. PubMed ID: 12970322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].
    Kroll TG; Sarraf P; Pecciarini L; Chen CJ; Mueller E; Spiegelman BM; Fletcher JA
    Science; 2000 Aug; 289(5483):1357-60. PubMed ID: 10958784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of PAX8-PPARG fusion transcripts in archival thyroid carcinoma samples by conventional RT-PCR.
    Klemke M; Drieschner N; Belge G; Burchardt K; Junker K; Bullerdiek J
    Genes Chromosomes Cancer; 2012 Apr; 51(4):402-8. PubMed ID: 22179975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.
    Lacroix L; Lazar V; Michiels S; Ripoche H; Dessen P; Talbot M; Caillou B; Levillain JP; Schlumberger M; Bidart JM
    Am J Pathol; 2005 Jul; 167(1):223-31. PubMed ID: 15972966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of PAX8-PPARgamma rearrangements is not specific to follicular thyroid carcinoma.
    Nakabashi CC; Guimarães GS; Michaluart P; Ward LS; Cerutti JM; Maciel RM
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):280-2. PubMed ID: 15272927
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.
    Zhu Z; Gandhi M; Nikiforova MN; Fischer AH; Nikiforov YE
    Am J Clin Pathol; 2003 Jul; 120(1):71-7. PubMed ID: 12866375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms.
    Chia WK; Sharifah NA; Reena RM; Zubaidah Z; Clarence-Ko CH; Rohaizak M; Naqiyah I; Srijit D; Hisham AN; Asmiati A; Rafie MK
    Cancer Genet Cytogenet; 2010 Jan; 196(1):7-13. PubMed ID: 19963130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
    Castro P; Rebocho AP; Soares RJ; Magalhães J; Roque L; Trovisco V; Vieira de Castro I; Cardoso-de-Oliveira M; Fonseca E; Soares P; Sobrinho-Simões M
    J Clin Endocrinol Metab; 2006 Jan; 91(1):213-20. PubMed ID: 16219715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value.
    Sahin M; Allard BL; Yates M; Powell JG; Wang XL; Hay ID; Zhao Y; Goellner JR; Sebo TJ; Grebe SK; Eberhardt NL; McIver B
    J Clin Endocrinol Metab; 2005 Jan; 90(1):463-8. PubMed ID: 15483076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogene.
    Lui WO; Foukakis T; Lidén J; Thoppe SR; Dwight T; Höög A; Zedenius J; Wallin G; Reimers M; Larsson C
    Oncogene; 2005 Feb; 24(8):1467-76. PubMed ID: 15608688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.
    Ferraz C; Rehfeld C; Krogdahl A; Precht Jensen EM; Bösenberg E; Narz F; Hegedüs L; Paschke R; Eszlinger M
    Thyroid; 2012 Oct; 22(10):1025-30. PubMed ID: 23025542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis of differentiated thyroid cancer (papillary and follicular)].
    Maciel RM; Kimura ET; Cerutti JM
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):691-700. PubMed ID: 16444351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma.
    Armstrong MJ; Yang H; Yip L; Ohori NP; McCoy KL; Stang MT; Hodak SP; Nikiforova MN; Carty SE; Nikiforov YE
    Thyroid; 2014 Sep; 24(9):1369-74. PubMed ID: 24798894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.